BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1559 related articles for article (PubMed ID: 35754217)

  • 21. Transanal total mesorectal excision for patients with rectal cancer : a Systematic review and meta-analysis.
    Ziati J; Souadka A; Benkabbou A; Boutayeb S; Ahmadi B; Amrani L; Mohsine R; Anass Majbar M
    Gulf J Oncolog; 2021 Jan; 1(35):66-76. PubMed ID: 33716215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of 26 studies.
    Li L; Wang T; Hu D; Wu D; Bi L; Luo Y; Guo Y; Yang X
    Int J Colorectal Dis; 2022 May; 37(5):1063-1071. PubMed ID: 35411470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME.
    Chen YT; Kiu KT; Yen MH; Chang TC
    Asian J Surg; 2019 Jun; 42(6):674-680. PubMed ID: 30318319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anastomotic leakage and chronic presacral sinus after transanal total mesorectal excision (taTME) for rectal cancer: A comparative study to laparoscopic TME.
    Jang HB; Kang SB; Lee H; Choi BJ; Lee SC
    Asian J Surg; 2022 Nov; 45(11):2197-2202. PubMed ID: 34801358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial.
    Liu H; Zeng Z; Zhang H; Wu M; Ma D; Wang Q; Xie M; Xu Q; Ouyang J; Xiao Y; Song Y; Feng B; Xu Q; Wang Y; Zhang Y; Hao Y; Luo S; Zhang X; Yang Z; Peng J; Wu X; Ren D; Huang M; Lan P; Tong W; Ren M; Wang J; Kang L;
    Ann Surg; 2023 Jan; 277(1):1-6. PubMed ID: 35815886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Risk Factors of Surgical Complications and Anastomotic Leakage After Transanal Total Mesorectal Excision for Middle and Low Rectal Cancer.
    Xu F; Li H; Guo C; Yang Z; Gao J; Zhang X; Wei Q; Meng C; Sun L; Wu G; Yao H; Zhang Z
    J Gastrointest Surg; 2023 Feb; 27(2):373-381. PubMed ID: 36538254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes.
    Lin D; Yu Z; Chen W; Hu J; Huang X; He Z; Zou YF; Yu X; Guo X; Wu XJ
    Wideochir Inne Tech Maloinwazyjne; 2019 Sep; 14(3):353-365. PubMed ID: 31534564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid-low rectal cancer in obese patients: outcomes of a multicenter propensity-matched analysis.
    Tejedor P; Arredondo J; Simó V; Zorrilla J; Baixauli J; Jiménez LM; Pastor C
    Updates Surg; 2023 Dec; 75(8):2191-2200. PubMed ID: 37903996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis.
    Alimova I; Chernyshov S; Nagudov M; Rybakov E
    Tech Coloproctol; 2021 Aug; 25(8):901-913. PubMed ID: 34002288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nationwide comparison of short-term outcomes after transanal, open, laparoscopic, and robot-assisted total mesorectal excision.
    Ose I; Perdawood SK
    Colorectal Dis; 2021 Oct; 23(10):2671-2680. PubMed ID: 34273239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of functional prognosis of transanal total mesorectal excision and conventional total mesorectal excision based on propensity score matching].
    Zhu LY; Zhao SD; Shen ZL; Ye YJ; Yin MJ; Yang XD; Xie QW; Jiang KW; Liang B; Wang S
    Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):619-625. PubMed ID: 32727194
    [No Abstract]   [Full Text] [Related]  

  • 35. Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision.
    Rubinkiewicz M; Zarzycki P; Witowski J; Pisarska M; Gajewska N; Torbicz G; Nowakowski M; Major P; Budzyński A; Pędziwiatr M
    BMC Surg; 2019 Jul; 19(1):79. PubMed ID: 31277628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of transanal total mesorectal excision for patients with middle and low rectal cancer: A systematic review and meta-analysis.
    Hu D; Jin P; Hu L; Liu W; Zhang W; Guo T; Yang X
    Medicine (Baltimore); 2018 Jul; 97(28):e11410. PubMed ID: 29995787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.
    Robertson RL; Karimuddin A; Phang T; Raval M; Brown C
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors.
    Procházka V; Grolich T; Farkašová M; Čan V; Svatoň R; Svoboda M; Ostřížková L; Eid M; Frola L; Bohatá Š; Kala Z
    Rozhl Chir; 2020; 99(3):124-130. PubMed ID: 32349496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.